share_log

Lei Liu Bought 516% More Shares In China Jo-Jo Drugstores

Lei Liu Bought 516% More Shares In China Jo-Jo Drugstores

刘磊购买了九洲大药房更多的股份516%
Simply Wall St ·  09/07 09:42

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) shareholders (or potential shareholders) will be happy to see that the Chairman & CEO, Lei Liu, recently bought a whopping US$4.7m worth of stock, at a price of US$1.87. That purchase boosted their holding by 516%, which makes us wonder if the move was inspired by quietly confident deeply-felt optimism.

九洲大药房(NASDAQ:CJJD)的股东(或潜在股东)会高兴地看到,董事长兼首席执行官刘磊最近以1,870万美元的价格购买了令人瞩目的470万美元的股票。这次购买增加了他们的持股比例516%,这让我们想知道这一举动是否源于内心深处的乐观情绪。

The Last 12 Months Of Insider Transactions At China Jo-Jo Drugstores

在最后十二个月中,九洲大药房内部交易中的最新交易数据显示:实际上,根据我们的记录,刘磊最近的购买是该公司股票内部个人交易中最大的一笔交易。这意味着一个内部人士愿意以高于当前价格1.51美元的价格购买股票。他们很可能对这次购买感到后悔,但更有可能他们对该公司持看好态度。在我们看来,内部人士购买股票的价格非常重要。一般规则是,当内部人士以高于当前价格购买股票时,我们对该股更为积极乐观,因为这意味着他们认为该股具有较高的价值,即使价格较高。刘磊是过去一年中唯一一位个人内部人士购买股票的人。

In fact, the recent purchase by Lei Liu was the biggest purchase of China Jo-Jo Drugstores shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at above the current price of US$1.51. It's very possible they regret the purchase, but it's more likely they are bullish about the company. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Lei Liu was the only individual insider to buy during the last year.

根据我们的记录,刘磊最近的购买是九洲大药房内部人士在过去十二个月中所作出的最大交易,这表明他们愿意以高于1.51美元的当前价格购买股票。他们很可能对这次购买感到后悔,但更有可能他们对该公司持看好态度。在我们看来,内部人士购买股票的价格非常重要。一般规则是,当内部人士以高于当前价格购买股票时,我们对该股更为积极乐观,因为这意味着他们认为该股具有较高的价值,即使价格较高。刘磊是过去一年中唯一一位个人内部人士购买股票的人。

The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

以下图表显示了过去一年中公司和个人的内部交易。单击下面的图表,即可查看每个内部交易的详细信息!

big
NasdaqCM:CJJD Insider Trading Volume September 7th 2024
纳斯达克CM:CJJD 内部交易成交量 2024年9月7日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

还有很多其他的公司,公司的内部人士正在购买股票。你可能不想错过这个免费的小市值公司的低估列表。

Insider Ownership

内部人员持股情况

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. It's great to see that China Jo-Jo Drugstores insiders own 45% of the company, worth about US$4.5m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

许多投资者喜欢查看公司内部持股比例。我们通常喜欢看到较高水平的内部持股。看到九洲大药房内部持股占公司的45%,价值约450万美元,感到很高兴。我喜欢看到这种水平的内部持股,因为它增加了管理层考虑股东最佳利益的机会。

So What Do The China Jo-Jo Drugstores Insider Transactions Indicate?

那么九洲大药房内部交易究竟暗示着什么?

The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about China Jo-Jo Drugstores. Looks promising! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Case in point: We've spotted 4 warning signs for China Jo-Jo Drugstores you should be aware of, and 2 of them don't sit too well with us.

最近的内部购买令人振奋。而长期的内部交易也让我们充满信心。然而,我们注意到公司在过去十二个月内没有盈利,这让我们感到谨慎。除了高内部持股外,这一分析表明内部人士对九洲大药房抱有较看好态度。看起来很有前途!虽然了解内部人士的持股和交易情况是很好的,但在做出任何投资决策之前,我们确保也考虑了一支股票面临的风险。例子如下:我们发现了4个对九洲大药房的警示信号,您应该注意其中有2个让我们不太满意。

Of course China Jo-Jo Drugstores may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,九洲大药房可能不是最佳的股票购买选择。因此,您可能希望查看这些高质量公司的免费选股套件。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发